In the wake of Joe Biden’s win of the 2020 presidential election, the Endocrine Society has looked at what a change in presidential administration could mean for its policy agenda and provided a few predictions: Immediate Priorities The “lame duck” period and first 100 days of a Biden Administration will likely be dominated by urgent efforts...
On October 14, the European Commission issued a Communication describing the European Union’s “Chemicals Strategy for Sustainability Towards a Toxic-Free Environment,” as part of the EU Green Deal. The strategy is designed to be the foundation for the most significant update to Europe’s chemical regulations in more than a decade. The Endocrine Society has advocated...
As Congress was not able to come to an agreement on the appropriations bills to fund the federal government for the next fiscal year (FY) in advance of the September 31 deadline, policy makers instead passed a Continuing Resolution that essentially funds the government at the prior year levels through December 11 2020. While it...
On September 9, the House Science, Space, and Technology Committee conducted a hearing about “The Impact of the COVID-19 Crisis on University Research.” While delivering their opening remarks, Haley Stevens (D-MI), chairwoman of the Subcommittee on Research and Technology, and Eddie Bernice Johnson (D-TX), chairwoman of the full Committee, spoke about the financial pressures facing...
On September 17, members of the Endocrine Society joined over 400 advocates to call on the Congress to provide increased funding for biomedical research as part of the 8th Annual Rally for Medical Research. Although the COVID-19 pandemic prevented participants from gathering in-person, Rally organizers were able to arrange tele- and videoconference meetings for research...
On June 11, the National Institutes of Health (NIH) announced the appointment of Rick Woychik, PhD, as director of the National Institute of Environmental Health Sciences (NIEHS) and National Toxicology Program (NTP). Woychik has been serving as the Acting Director of NIEHS since October 2019 following the retirement of the previous Director, Linda Birnbaum, PhD....
With the severe disruption to research activity due to the COVID-19 pandemic causing strain at labs across the country, the National Institutes of Health (NIH) has had to quickly address the situation for the workforce while also mobilizing to support research activities related to the virus and comorbidities. Despite the extreme challenge of the situation,...
As the pandemic took hold in the U.S. and communities implemented strict social distancing measures, including stay-at-home orders, the Endocrine Society pivoted its advocacy approach to Congress and launched a strategic “virtual” Hill Day to advocate our recommendations for relief legislation. Originally, the Society had planned a Hill Day for April 20 to bring members...
In the wake of Joe Biden’s win of the 2020 presidential election, the Endocrine Society has looked at what a change in presidential administration could mean for its policy agenda and provided a few predictions: Immediate Priorities The “lame duck” period and first 100 days of a Biden Administration will likely be dominated by urgent efforts...
On September 17, members of the Endocrine Society joined over 400 advocates to call on the Congress to provide increased funding for biomedical research as part of the 8th Annual Rally for Medical Research. Although the COVID-19 pandemic prevented participants from gathering in-person, Rally organizers were able to arrange tele- and videoconference meetings for research...
